Stirling Square Acquires Eurofins Digital Testing
September 1, 2022
Stirling Square Capital Partners has agreed to acquire Eurofins Scientific’s Digital Testing business for €220 million on a cash- and debt-free basis. The divested business — which was established in 2015, provides digital testing, quality assurance and cybersecurity services and employs over 600 staff — will be subject to regulatory approvals and customary closing conditions; Baird acted as exclusive financial advisor to Eurofins.
- Buyers
- Stirling Square Capital Partners
- Targets
- Eurofins Digital Testing
- Sellers
- Eurofins Scientific
- Industry
- IT Services
- Location
- United Kingdom
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Eurofins Scientific Acquires Infinity Laboratories
September 16, 2024
Healthcare Services
Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.
-
Eurofins Scientific Acquires WESSLING Hungary
July 29, 2022
Environmental Services
Eurofins Scientific has completed the acquisition of WESSLING Hungary, a Budapest-based environmental, food and BioPharma product testing laboratory. The deal expands Eurofins’ laboratory footprint and capabilities in Hungary and Central and Eastern Europe, adding ~€15m in revenue and over 300 employees.
-
Eurofins (via Eurofins Clinical Testing Lux) Acquires Genetic Testing Service JSC (Gentis) in Vietnam
February 9, 2022
Healthcare Services
Eurofins Scientific, through its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a market leader in specialised genetic testing in Vietnam. The deal expands Eurofins' footprint in Southeast Asia and strengthens its clinical genetics and advanced molecular diagnostics capabilities in the region.
-
Eurofins Scientific Acquires bioskin GmbH
August 4, 2021
Healthcare Services
Eurofins Scientific has completed the acquisition of bioskin GmbH, a Hamburg-based dermatology-focused CRO that provides clinical trials for drugs, medical devices, food supplements and advanced cosmetics. The deal expands Eurofins' clinical study management and dermatology capabilities in Germany and strengthens its Cosmetics & Personal Care testing offering.
-
Eurofins Acquires Genetic Testing Service JSC (Gentis) in Vietnam
February 9, 2022
Healthcare Services
Eurofins Scientific, via its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a leading provider of specialised genetic and clinical testing in Vietnam. The acquisition expands Eurofins' clinical diagnostics footprint in Southeast Asia and adds Gentis' genetic testing capabilities and customer relationships with hospitals and consumers.
-
Eurofins Acquires DNA Diagnostics Center from GHO Capital
June 28, 2021
Healthcare Services
Eurofins, the publicly traded global laboratory testing group, has agreed to acquire DNA Diagnostics Center (DDC), a consumer-focused DNA testing company based in Fairfield, Ohio, from GHO Capital. DDC, which has approximately 240 employees and a broad portfolio of at‑home and lab-based DNA tests, will join Eurofins to expand its consumer genetics and health & wellness testing capabilities and global reach.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.